1. Amin-Hanjani S, Du X, Mlinarevich N, Meglio G, Zhao M, Charbel FT. The cut flow index: an intraoperative predictor of the success of extracranial-intracranial bypass for occlusive cerebrovascular disease. Neurosurgery. 56(1 Suppl):75–85. discussion 75-85. 2005.
2. Beverly JK, Budoff MJ. Atherosclerosis: pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 12:102–104. 2020.
3. Hage ZA, Behbahani M, Amin-Hanjani S, Charbel FT. Carotid bypass for carotid occlusion. Curr Atheroscler Rep. 17:36. 2015.
4. Helthuis JHG, van Doormaal TPC, Amin-Hanjani S, Du X, Charbel FT, Hillen B, et al. A patient-specific cerebral blood flow model. J Biomech. 98:109445. 2020.
5. Kuriyama S, Kusaka Y, Fujimura M, Wakai K, Tamakoshi A, Hashimoto S, et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: findings from a nationwide epidemiological survey. Stroke. 39:42–47. 2008.
6. Liu JK, Kan P, Karwande SV, Couldwell WT. Conduits for cerebrovascular bypass and lessons learned from the cardiovascular experience. Neurosurg Focus. 14:e3. 2003.
7. Markert MS, Della-Morte D, Cabral D, Roberts EL Jr, Gardener H, Dong C, et al. Ethnic differences in carotid artery diameter and stiffness: the Northern Manhattan study. Atherosclerosis. 219:827–832. 2011.
8. Matsukawa H, Tanikawa R, Kamiyama H, Tsuboi T, Noda K, Ota N, et al. The valveless saphenous vein graft technique for EC-IC high-flow bypass: technical note. World Neurosurg. 87:35–38. 2016.
9. Mohit AA, Sekhar LN, Natarajan SK, Britz GW, Ghodke B. High-flow bypass grafts in the management of complex intracranial aneurysm. Neurosurgery. 60(2 Suppl 1):ONS105–ONS122. discussion ONS122-ONS123. 2007.
10. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C. Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke. 29:625–630. 1998.
11. Sekhar LN, Natarajan SK, Ellenbogen RG, Ghodke B. Cerebral revascularization for ischemia, aneurysms, and cranial base tumors. Neurosurgery. 62(6 Suppl 3):SHC1373–SHC1410. discussion 1408-1410. 2008.
12. Stapleton CJ, Atwal GS, Hussein AE, Amin-Hanjani S, Charbel FT. The cut flow index revisited: utility of intraoperative blood flow measurements in extracranial-intracranial bypass surgery for ischemic cerebrovascular disease. J Neurosurg. 133:1396–1400. 2019.
13. Tulleken CA, van der Zwan A, Kappelle LJ. High-flow transcranial bypass for prevention of brain ischemia. Ned Tijdschr Geneeskd. 143:2281–2285. 1999.
14. Unda SR, Antoniazzi AM, Fluss R, Yassari N, Esenwa C, Haranhalli N, et al. Ethnic-associated phenotype variations in moyamoya cerebrovascular outcomes. Cerebrovasc Dis. 52:519–525. 2023.
15. Wang G, Zhang X, Wang B, Wen Y, Chen S, Liu J, et al. Flow evaluation of STA-MCA bypass using quantitative ultrasonography: an alternative to standard angiography for follow up of bypass graft. J Stroke Cerebrovasc Dis. 29:105000. 2020.
16. Zechariah A, ElAli A, Hagemann N, Jin F, Doeppner TR, Helfrich I, et al. Hyperlipidemia attenuates vascular endothelial growth factor-induced angiogenesis, impairs cerebral blood flow, and disturbs stroke recovery via decreased pericyte coverage of brain endothelial cells. Arterioscler Thromb Vasc Biol. 33:1561–1567. 2013.